SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-103142
Filing Date
2024-09-26
Accepted
2024-09-26 16:10:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2424760d1_424b5.htm 424B5 275045
2 GRAPHIC tm2424760d1_424b5img001.jpg GRAPHIC 2486
3 GRAPHIC tm2424760d1_424b5img002.jpg GRAPHIC 32924
  Complete submission text file 0001104659-24-103142.txt   325501
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279077 | Film No.: 241329064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)